JPRN-UMIN000006614已完成未知
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) -Investigation of response to proton pump inhibitor (PPI) therapy and factors involved- - A prospective fact-finding study on the treatment of gastroesophageal reflux disease (GERD)
GERD Society0 个研究点目标入组 500 人开始时间: 2011年10月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with a history of gastrointestinal resection or vagotomy 2)Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia), or sudden weight loss 3)Patients with concurrent peptic ulcer (not in the scarring stage) 4)Patients with a prior or current history of any of the following diseases: - Zollinger-Ellison syndrome - Inflammatory bowel disease (IBD) - Irritable bowel syndrome (IBS) - Esophageal stricture - Eosinophilic reflux esophagitis - Esophageal achalasia - Malabsorption - Cerebrovascular disorders such as cerebral hemorrhage and cerebral infarction 5)Patients complicated by serious hepatic, renal, cardiac, or other diseases for which the participation in the study would be difficult 6)Patients with a confirmed or suspected malignant lesion 7)Patients who are pregnant, breastfeeding, or may be pregnant 8)Patients considered to require continued use of any drugs that could interact with the study drugs (i.e., atazanavir sulfate, diazepam, phenytoin, warfarin, tacrolimus hydrate, digoxin, methyldigoxin, itraconazole, gefitinib, voriconazole, antacids containing aluminium hydroxide gel and magnesium hydroxide, and clopidogrel) 9)Patients with a history of hypersensitivity to any components of proton pump inhibitor products 10)Patients who received a proton pump inhibitor or an H2-receptor antagonist within one week prior to enrollment in this study 11)Patients who underwent H. pylori eradication within six months prior to the start of the study 12)Patients with any concurrent disease interfering with normal living (e.g., psychiatric disease, poorly controlled metabolic disease, neurological disease, collagen disease) 13)Other patients judged by the physician to be inappropriate for this study
研究者
相似试验
已完成
不适用
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Prospective study on therapeutic effects of proton pump inhibitors on reflux esophagitisJPRN-UMIN000005271GERD Society120
已完成
不适用
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Retrospective study on therapeutic effects of proton pump inhibitors on reflux esophagitisgastroesophageal reflux disease (GERD)JPRN-UMIN000005272GERD Society500
招募中
1 期
Clinical study on the treatment of gastroesophageal reflux cough by the reverse embedding method of tongdu xuanfeiITMCTR2100004898anjing Hospital of Traditional Chinese Medicine
尚未招募
不适用
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
已完成
Unknown
Research study on the treatment patterns of gastrointestinal stromal tumor (GIST) using the claims databaseJPRN-UMIN000054074TAIHO PHARMACEUTICAL CO., LTD.1,847